Inovio Pharmaceuticals, Inc. (INO) vs Nutriband Inc. (NTRB)
A side-by-side comparison of Inovio Pharmaceuticals, Inc. and Nutriband Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
INO
Inovio Pharmaceuticals, Inc.
$1.13HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
NTRB
Nutriband Inc.
$6.68HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — INO vs NTRB
growth of $100 · dividends reinvested · last 5yINO -98.7% (-57.8%/yr)NTRB +30.1% (+5.4%/yr)NTRB compounded faster over this window
Log scale — wide-divergence pair
INO NTRB
INO vs NTRB: by the numbers
- •NTRB is the larger company ($81M vs $78M market cap).
- •Both run net losses; NTRB's is the smaller (-430.43% vs -130000.00% net margin).
Metrics side by side
Valuation
| Metric | INO | NTRB |
|---|---|---|
| Forward P/E | N/A | 4.25 |
| P/S ratio | N/A | 50.20 |
| P/B ratio | 17.86 | 15.25 |
Profitability
| Metric | INO | NTRB |
|---|---|---|
| Gross margin | 100.00% | 33.14% |
| Operating margin | -132871.32% | -408.41% |
| Net margin | -130000.00% | -430.43% |
| ROE | -1542.57% | -130.67% |
| ROIC | -836.58% | -126.99% |
Growth (annualized)
| Metric | INO | NTRB |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 3.12% |
| Total return CAGR (5Y) | -57.05% | 6.67% |
Frequently asked
- How have INO and NTRB total returns compared?
- Over the past 5 years, INO delivered -57.05% and NTRB delivered 6.67% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.